Telehealth Practice Standards
The modification in prescribing regulations is expected to have significant implications for healthcare providers and patients accessing telehealth services. By allowing telehealth providers to prescribe certain controlled substances under specific conditions—such as for treating psychiatric disorders, for patients receiving hospice care, and for residents of nursing facilities—the bill acknowledges the increasing reliance on telehealth, especially in the wake of the COVID-19 pandemic. It facilitates greater access to care for vulnerable populations, while also emphasizing the safety measures around the prescription of potent medications.
House Bill 0017, titled 'Telehealth Practice Standards,' aims to amend the existing regulations related to telehealth in Florida. Specifically, it modifies section 456.47 of the Florida Statutes, revising the prohibitions on the ability to prescribe controlled substances via telehealth. The bill narrows the scope of controlled substances that can be prescribed using this method and lists specific circumstances under which such prescriptions can occur. This move aims to align telehealth practices with necessary and appropriate care standards while addressing concerns about the safe use of controlled substances in remote consultations.
House Bill 0017 represents a progressive step in reshaping telehealth regulations to better suit the evolving landscape of healthcare delivery. By setting clear boundaries on the prescription of controlled substances, it aims to enhance both access and safety for those relying on telehealth services. The effective date for the bill is set for July 1, 2022, allowing for adjustments in practice standards across the state.
While the bill primarily received support, there are concerns raised by some stakeholders about potential misuse and the adequacy of monitoring prescriptions made through telehealth. Critics worry that easing restrictions without stringent oversight may lead to over-prescribing and undermine the integrity of healthcare delivery. Notably, the bill stipulates that controlled substances from Schedule II, which can be highly addictive, will only be prescribed in defined situations, a measure supported by advocates of safer healthcare practices.